|Grant Affiliation:||Haynes: B-Cell Lineage Envelope Design|
|Strategy:||Prophylactic neutralizing Ab|
|Study Type:||Antibody Screening|
|Study Start Date:||2012-07-06|
|Study Made Public:||2016-01-15|
Characterization of monoclonal antibodies from RV144 vaccine recipients
CAVD 374 is an immunogenicity study to identify and characterize monoclonal antibodies from vaccine recipients in the human clinical trial, RV144.
Sign in to see full information about this study and to download study data.